{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T10:33:37Z","timestamp":1781174017042,"version":"3.54.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.anai.2023.01.006","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T02:02:02Z","timestamp":1673661722000},"page":"628-636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Drug patch testing in Stevens-Johnson syndrome and toxic epidermal necrolysis"],"prefix":"10.1016","volume":"130","author":[{"given":"Danielle E.","family":"Novack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Braskett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Worswick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon L.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.anai.2023.01.006_bib0001","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/bjd.15423","article-title":"Recent advances in the understanding of severe cutaneous adverse reactions","volume":"177","author":"Adler","year":"2017","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2023.01.006_bib0002","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.anai.2023.01.006_bib0003","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jid.2017.01.031","article-title":"The epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UK","volume":"137","author":"Frey","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.anai.2023.01.006_bib0004","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry","volume":"49","author":"Rzany","year":"1996","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.anai.2023.01.006_bib0005","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.jid.2016.03.023","article-title":"Morbidity and mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis in United States adults","volume":"136","author":"Hsu","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2023.01.006_bib0006","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaci.2018.10.030","article-title":"Controversies in drug allergy: testing for delayed reactions","volume":"143","author":"Phillips","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.01.006_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2021","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.anai.2023.01.006_bib0008","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/DER.0000000000000839","article-title":"Patch testing in drug eruptions: practical aspects and literature review of eruptions and culprit drugs","volume":"33","author":"de Groot","year":"2022","journal-title":"Dermatitis"},{"key":"10.1016\/j.anai.2023.01.006_bib0009","series-title":"Systemic Drugs","article-title":"Monographs in Contact Allergy","volume":"4","author":"de Groot","year":"2022"},{"issue":"5","key":"10.1016\/j.anai.2023.01.006_bib0010","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/pai.12565","article-title":"Non-immediate hypersensitivity reactions to beta-lactam antibiotics in children\u2014our 10-year experience in allergy work-up","volume":"27","author":"Atanaskovic-Markovic","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.01.006_bib0011","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/pai.13055","article-title":"Hypersensitivity reactions to antiepileptic drugs in children","volume":"30","author":"Atanaskovic-Markovic","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"issue":"11","key":"10.1016\/j.anai.2023.01.006_bib0012","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/ijd.13306","article-title":"The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions","volume":"55","author":"Hassoun-Kheir","year":"2016","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2023.01.006_bib0013","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/cea.13513","article-title":"Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: a 9-year experience in a tertiary care paediatric hospital setting","volume":"50","author":"Liccioli","year":"2020","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.anai.2023.01.006_bib0014","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archderm.1991.01680050095011","article-title":"T-cell subsets in drug-induced toxic epidermal necrolysis: possible pathogenic mechanism induced by CD8-positive T cells","volume":"127","author":"Miyauchi","year":"1991","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.anai.2023.01.006_bib0015","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000248010","article-title":"Management of nonstaphylococcal toxic epidermal necrolysis: follow-up study of 16 case histories","volume":"180","author":"Tegelberg-Stassen","year":"1990","journal-title":"Dermatologica"},{"issue":"1","key":"10.1016\/j.anai.2023.01.006_bib0016","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/bjd.14492","article-title":"Diagnostic patch testing following tuberculosis-associated cutaneous adverse drug reactions induces systemic reactions in HIV-infected persons","volume":"175","author":"Lehloenya","year":"2016","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2023.01.006_bib0017","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00281-015-0540-2","article-title":"Adverse cutaneous drug eruptions: current understanding","volume":"38","author":"Hoetzenecker","year":"2016","journal-title":"Semin Immunopathol"},{"issue":"1-2","key":"10.1016\/j.anai.2023.01.006_bib0018","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/08820538.2015.1115255","article-title":"Immunologic mediators in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"31","author":"Saeed","year":"2016","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.anai.2023.01.006_bib0019","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.3389\/fimmu.2021.654190","article-title":"Skin resident memory T cells may play critical role in delayed-type drug hypersensitivity reactions","volume":"12","author":"Schunkert","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.01.006_bib0020","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/cod.12720","article-title":"Long-term reproducibility of positive patch test reactions in patients with non-immediate cutaneous adverse drug reactions to antibiotics","volume":"76","author":"Pinho","year":"2017","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.anai.2023.01.006_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"Harr","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.anai.2023.01.006_bib0022","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4103\/0022-3859.81865","article-title":"Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study","volume":"57","author":"Barvaliya","year":"2011","journal-title":"J Postgrad Med"},{"issue":"3","key":"10.1016\/j.anai.2023.01.006_bib0023","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s12016-022-08924-2","article-title":"The role of patch testing in evaluating delayed hypersensitivity reactions to medications","volume":"62","author":"Woodruff","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.anai.2023.01.006_bib0024","series-title":"Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions: Current and Future Trends","first-page":"247","article-title":"In vitro and in vivo tests in cutaneous adverse drug reactions. In: Shear NH, Dodiuk-Gad RP, eds","author":"Barbaud","year":"2019"},{"issue":"6","key":"10.1016\/j.anai.2023.01.006_bib0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1034\/j.1600-0536.2001.450601.x","article-title":"Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions","volume":"45","author":"Barbaud","year":"2001","journal-title":"Contact Dermatitis"},{"issue":"5","key":"10.1016\/j.anai.2023.01.006_bib0026","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/cod.14063","article-title":"Skin tests in the work-up of cutaneous adverse drug reactions: a review and update","volume":"86","author":"Barbaud","year":"2022","journal-title":"Contact Dermatitis"},{"issue":"5","key":"10.1016\/j.anai.2023.01.006_bib0027","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archderm.1994.01690050066011","article-title":"Investigations of mechanisms in toxic epidermal necrolysis induced by carbamazepine","volume":"130","author":"Friedmann","year":"1994","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.anai.2023.01.006_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11882-014-0442-8","article-title":"Skin testing and patch testing in non-IgE-mediated drug allergy","volume":"14","author":"Barbaud","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"10.1016\/j.anai.2023.01.006_bib0029","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-3083.2011.04418.x","article-title":"A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions","volume":"27","author":"Lin","year":"2013","journal-title":"J Eur Acad Dermatology Venereol"},{"issue":"4","key":"10.1016\/j.anai.2023.01.006_bib0030","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-0536.1996.tb02364.x","article-title":"Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"35","author":"Wolkenstein","year":"1996","journal-title":"Contact Dermatitis"},{"issue":"7","key":"10.1016\/j.anai.2023.01.006_bib0031","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/pai.12121","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis in children","volume":"24","author":"Atanaskovi\u0107-Markovi\u0107","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"issue":"9","key":"10.1016\/j.anai.2023.01.006_bib0032","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/jac\/dkv158","article-title":"Lack of cross-toxicity between isoniazid and ethionamide in severe cutaneous adverse drug reactions: a series of 25 consecutive confirmed cases","volume":"70","author":"Lehloenya","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.anai.2023.01.006_bib0033","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/11593240-000000000-00000","article-title":"Incidence of toxic epidermal necrolysis and Stevens-Johnson syndrome in an HIV cohort: an observational, retrospective case series study","volume":"13","author":"Mittmann","year":"2012","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.anai.2023.01.006_bib0034","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/ACI.0000000000000545","article-title":"Drug hypersensitivity in HIV infection","volume":"19","author":"Peter","year":"2019","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.01.006_bib0035","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jaci.2005.10.030","article-title":"Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions","volume":"117","author":"Beeler","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.01.006_bib0036","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/all.14146","article-title":"The role of drug, dose, and the tolerance\/intolerance of new drugs in multiple drug hypersensitivity syndrome","volume":"75","author":"J\u00f6rg","year":"2020","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.01.006_bib0037","first-page":"53","article-title":"Two cases of toxic epidermal necrolysis caused by delayed hypersensitivity to \u03b2-lactam antibiotics","volume":"3","author":"Romano","year":"1993","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.01.006_bib0038","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjd.12125","article-title":"A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions","volume":"168","author":"Barbaud","year":"2013","journal-title":"Br J Dermatol"},{"issue":"20","key":"10.1016\/j.anai.2023.01.006_bib0039","first-page":"865","article-title":"[Allergological studies of the Lyell syndrome]","volume":"50","author":"Sch\u00f6pf","year":"1975","journal-title":"Z Hautkr"},{"issue":"11","key":"10.1016\/j.anai.2023.01.006_bib0040","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1001\/archderm.1983.01650350038011","article-title":"Delayed hypersensitivity in ampicillin-induced toxic epidermal necrolysis","volume":"119","author":"Tagami","year":"1983","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.anai.2023.01.006_bib0041","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1346-8138.2005.tb00914.x","article-title":"Bucillamine-induced toxic epidermal necrolysis and fixed drug eruption","volume":"32","author":"Izumi","year":"2005","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.anai.2023.01.006_bib0042","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-0536.1985.tb02565.x","article-title":"Toxic epidermal necrolysis due to erythromycin","volume":"13","author":"Kofoed","year":"1985","journal-title":"Contact Dermatitis"},{"issue":"2","key":"10.1016\/j.anai.2023.01.006_bib0043","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/jdv.13796","article-title":"Patch testing - a valuable tool for investigating non-immediate cutaneous adverse drug reactions to antibiotics","volume":"31","author":"Pinho","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.anai.2023.01.006_bib0044","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-0536.2006.00904.x","article-title":"Stevens-Johnson syndrome from metronidazole","volume":"55","author":"Piskin","year":"2006","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.anai.2023.01.006_bib0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.0105-1873.2004.00280.x","article-title":"Drug skin tests in cutaneous adverse drug reactions to pristinamycin: 29 cases with a study of cross-reactions between synergistins","volume":"50","author":"Barbaud","year":"2004","journal-title":"Contact Dermatitis"},{"issue":"4","key":"10.1016\/j.anai.2023.01.006_bib0046","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/bjd.16738","article-title":"Polysensitivity in delayed cutaneous adverse drug reactions to macrolides, clindamycin and pristinamycin: clinical history and patch testing","volume":"179","author":"El Khoury","year":"2018","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.anai.2023.01.006_bib0047","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-0536.1996.tb02339.x","article-title":"Patch testing in an unusual case of toxic epidermal necrolysis","volume":"35","author":"Klein","year":"1996","journal-title":"Contact Dermatitis"},{"issue":"2","key":"10.1016\/j.anai.2023.01.006_bib0048","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2500\/aap.2021.42.200110","article-title":"Evaluation of drug patch tests in children","volume":"42","author":"Yaytokgil","year":"2021","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"10.1016\/j.anai.2023.01.006_bib0049","first-page":"365","article-title":"Patch testing in the detection of cutaneous reactions caused by carbamazepine","volume":"38","author":"Liao","year":"1997","journal-title":"Acta Paediatr Sin"},{"issue":"5","key":"10.1016\/j.anai.2023.01.006_bib0050","first-page":"539","article-title":"Place du patch-test dans le diagnostic des r\u00e9actions d'hypersensibilit\u00e9s retard\u00e9es induites par les anti\u00e9pileptiques","volume":"72","author":"Ben Mahmoud","year":"2017","journal-title":"Th\u00e9rapie"},{"issue":"4","key":"10.1016\/j.anai.2023.01.006_bib0051","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2125.2003.01816.x","article-title":"Antiepileptic drug hypersensitivity syndrome in a patient treated with valproate","volume":"55","author":"Ar\u00e9valo-Lorido","year":"2003","journal-title":"Br J Clin Pharmacol"},{"issue":"26","key":"10.1016\/j.anai.2023.01.006_bib0052","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.2174\/138161206778193962","article-title":"Hypersensitivity to aromatic anticonvulsants: in vivo and in vitro cross-reactivity studies","volume":"12","author":"Romano","year":"2006","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.anai.2023.01.006_bib0053","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1079-9796(03)00004-4","article-title":"Differences in the immunological responses in drug- and virus-induced cutaneous reactions in children","volume":"30","author":"Torres","year":"2003","journal-title":"Blood Cells Mol Dis"},{"issue":"5","key":"10.1016\/j.anai.2023.01.006_bib0054","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/cod.13928","article-title":"Ethosuximide-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis overlap confirmed by patch testing in a child","volume":"85","author":"Matos","year":"2021","journal-title":"Contact Dermatitis"},{"issue":"2","key":"10.1016\/j.anai.2023.01.006_bib0055","first-page":"55","article-title":"Stevens-Johnson syndrome from tetrazepam","volume":"26","author":"S\u00e1nchez","year":"1998","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"3","key":"10.1016\/j.anai.2023.01.006_bib0056","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1034\/j.1600-0536.2002.470302.x","article-title":"Tetrazepam drug sensitivity\u2014usefulness of the patch test","volume":"47","author":"Pirker","year":"2002","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.anai.2023.01.006_bib0057","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-0536.2009.01558.x","article-title":"No cross-reactions between tetrazepam and other benzodiazepines: a possible chemical explanation","volume":"61","author":"Barbaud","year":"2009","journal-title":"Contact Dermatitis"},{"issue":"11","key":"10.1016\/j.anai.2023.01.006_bib0058","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1034\/j.1398-9995.1999.00362.x","volume":"54","author":"Del Pozo","year":"1999","journal-title":"Tetrazepam allergy. Allergy"},{"issue":"5","key":"10.1016\/j.anai.2023.01.006_bib0059","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/cod.12842","article-title":"Patch testing in non-immediate cutaneous adverse drug reactions: value of extemporaneous patch tests","volume":"77","author":"Assier","year":"2017","journal-title":"Contact Dermatitis"},{"issue":"4","key":"10.1016\/j.anai.2023.01.006_bib0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/cod.12508","article-title":"Severe reaction to emtricitabine and lamiduvine: evidence of cross-reactivity","volume":"74","author":"Su\u00e1rez-Lorenzo","year":"2016","journal-title":"Contact Dermatitis"},{"issue":"3","key":"10.1016\/j.anai.2023.01.006_bib0061","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3835(90)90030-2","article-title":"Unusual reaction to chlorambucil: a case report","volume":"54","author":"Pietrantonio","year":"1990","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.anai.2023.01.006_bib0062","first-page":"13","article-title":"Patch tests in adverse cutaneous drug reaction","volume":"68","author":"Balachandran","year":"2022","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"10.1016\/j.anai.2023.01.006_bib0063","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/cod.12641","article-title":"Patch testing in the investigation of non-immediate cutaneous adverse drug reactions to metamizole","volume":"76","author":"Pinho","year":"2017","journal-title":"Contact Dermatitis"},{"issue":"6","key":"10.1016\/j.anai.2023.01.006_bib0064","first-page":"367","article-title":"Positive patch test to diclofenac in Stevens-Johnson syndrome","volume":"42","author":"Alonso","year":"2000","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.anai.2023.01.006_bib0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/all.13235","article-title":"Delayed-type hypersensitivity reactions induced by proton pump inhibitors: a clinical and in vitro T-cell reactivity study","volume":"73","author":"Lin","year":"2018","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2023.01.006_bib0066","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/jdv.16814","article-title":"Positive patch testing with omeprazole in Stevens-Johnson syndrome: a case report","volume":"35","author":"Van Tendeloo","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.anai.2023.01.006_bib0067","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00105-010-1993-9","article-title":"Dithiols as chelators. A cause of bullous skin reactions","volume":"62","author":"Storim","year":"2011","journal-title":"Hautarzt"},{"issue":"2","key":"10.1016\/j.anai.2023.01.006_bib0068","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.5415\/apallergy.2021.11.e17","article-title":"A case of bortezomib (Velcade)-induced Stevens-Johnson syndrome confirmed by patch test","volume":"11","author":"Choi","year":"2021","journal-title":"Asia Pac Allergy"},{"issue":"3","key":"10.1016\/j.anai.2023.01.006_bib0069","doi-asserted-by":"crossref","first-page":"191","DOI":"10.18176\/jiaci.0158","article-title":"Stevens-Johnson syndrome\/toxic epidermal necrolysis overlap induced by fexofenadine","volume":"27","author":"Teo","year":"2017","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.01.006_bib0070","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2214\/ajr.176.1.1760262","article-title":"Toxic epidermal necrolysis after repeated injections of iohexol","volume":"176","author":"Rosado","year":"2001","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.anai.2023.01.006_bib0071","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-0536.1999.tb06236.x","article-title":"Is terbinafine responsible for eliciting positive patch tests performed with Lamisil\u00ae tablets?","volume":"41","author":"Barbaud","year":"1999","journal-title":"Contact Dermatitis"},{"issue":"38","key":"10.1016\/j.anai.2023.01.006_bib0072","first-page":"1475","article-title":"A propranolol dermatitis mimicking Lyell\u2019s syndrome","volume":"121","author":"van Ketel","year":"1977","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"7","key":"10.1016\/j.anai.2023.01.006_bib0073","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archderm.141.7.907","article-title":"Pseudoephedrine-induced toxic epidermal necrolysis","volume":"141","author":"Nagge","year":"2005","journal-title":"Arch Dermatol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623000078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623000078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:32:23Z","timestamp":1761053543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120623000078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1081120623000078"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2023.01.006","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug patch testing in Stevens-Johnson syndrome and toxic epidermal necrolysis","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2023.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}